1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018, 68(6):394–424.
2.Yang KD, Gao J, Luo M: Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis. Oncotargets Ther 2019, 12:1319–1331.
3.Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z et al: Supervised risk predictor of breast cancer based on intrinsic subtypes. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009, 27(8):1160–1167.
4.Prat A, Ellis MJ, Perou CM: Practical implications of gene-expression-based assays for breast oncologists. Nature reviews Clinical oncology 2012, 9(1):48.
5.Feng YX, Spezia M, Huang SF, Yuan CF, Zeng ZY, Zhang LH, Ji XJ, Liu W, Huang B, Luo WP et al: Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 2018, 5(2):77–106.
6.Zhang H, Liang YC, Han SY, Peng C, Li Y: Long Noncoding RNA and Protein Interactions: From Experimental Results to Computational Models Based on Network Methods. Int J Mol Sci 2019, 20(6).
7.Tuersong T, Li LL, Abulaiti Z, Feng SM: Comprehensive analysis of the aberrantly expressed lncRNA-associated ceRNA network in breast cancer. Mol Med Rep 2019, 19(6):4697–4710.
8.Maire V, Némati F, Richardson M, Vincent-Salomon A, Tesson B, Rigaill G, Gravier E, Marty-Prouvost B, De Koning L, Lang G: Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer. Cancer research 2013, 73(2):813–823.
9.Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, Dubois T, Dutreix M, Vincent‐Salomon A, Miller KM: Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO molecular medicine 2016, 8(5):527–549.
10.Irizarry RA, Hobbs B, Collin F, Beazer‐Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249–264.
11.Zhang X, Sun S, Pu JKS, Tsang ACO, Lee D, Man VOY, Lui WM, Wong STS, Leung GKK: Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiology of disease 2012, 48(1):1–8.
12.Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids research 2015, 43(7):e47-e47.
13.Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T: Orchestrating high-throughput genomic analysis with Bioconductor. Nature methods 2015, 12(2):115.
14.Yeung KY, Ruzzo WL: Principal component analysis for clustering gene expression data. Bioinformatics 2001, 17(9):763–774.
15.Wickham H: ggplot2: elegant graphics for data analysis: Springer; 2016.
16.Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 2009, 4(1):44–57.
17.Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P: STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research 2018, 47(D1):D607-D613.
18.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 2003, 13(11):2498–2504.
19.Bader GD, Hogue CW: An automated method for finding molecular complexes in large protein interaction networks. BMC bioinformatics 2003, 4(1):2.
20.Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y: cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC systems biology 2014, 8(4):S11.
21.Tang Y, Li M, Wang J, Pan Y, Wu F-X: CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems 2015, 127:67–72.
22.Braschi B, Denny P, Gray K, Jones T, Seal R, Tweedie S, Yates B, Bruford E: Genenames. org: the HGNC and VGNC resources in 2019. Nucleic acids research 2018, 47(D1):D786-D792.
23.Nagy Á, Lánczky A, Menyhárt O, Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Scientific reports 2018, 8(1):9227.
24.Jiang L, Hong L, Yang W, Zhao Y, Tan A, Li Y: Co-expression network analysis of the lncRNAs and mRNAs associated with cervical cancer progression. Archives of medical science: AMS 2019, 15(3):754.
25.Zhuang DY, Jiang L, He QQ, Zhou P, Yue T: Identification of hub subnetwork based on topological features of genes in breast cancer. Int J Mol Med 2015, 35(3):664–674.
26.Fan ST, Liang ZM, Gao ZQ, Pan ZW, Han SJ, Liu XY, Zhao CL, Yang WW, Pan ZF, Feng WG: Identification of the key genes and pathways in prostate cancer. Oncol Lett 2018, 16(5):6663–6669.
27.Gou Q, Gong X, Jin JH, Shi JJ, Hou YZ: Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy. Oncotarget 2017, 8(36):60704–60709.
28.Li Y, Steppi A, Zhou YD, Mao F, Miller PC, He MM, Zhao TT, Sun Q, Zhang JF: Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine. Scientific Reports 2017, 7.
29.Li J, Han X: Adipocytokines and breast cancer. Current problems in cancer 2018, 42(2):208–214.
30.Fasoulakis Z, Kolios G, Papamanolis V, Kontomanolis EN: Interleukins Associated with Breast Cancer. Cureus 2018, 10(11).
31.Ni Z, Wang XT, Zhang TC, Li LL, Li JX: Comprehensive analysis of differential expression profiles reveals potential biomarkers associated with the cell cycle and regulated by p53 in human small cell lung cancer. Exp Ther Med 2018, 15(4):3273–3282.
32.May KM, Paldi F, Hardwick KG: Fission Yeast Apc15 Stabilizes MCC-Cdc20-APC/C Complexes, Ensuring Efficient Cdc20 Ubiquitination and Checkpoint Arrest. Current biology: CB 2017, 27(8):1221–1228.
33.Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D: Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell 1989, 56(5):829–838.
34.Fisher D, Nurse P: Cyclins of the fission yeast Schizosaccharomyces pombe. Seminars in cell biology 1995, 6(2):73–78.
35.Nasmyth K: Viewpoint: putting the cell cycle in order. Science (New York, NY) 1996, 274(5293):1643–1645.